Berita

Pfizer Profit Surges, Reaffirms Sales Forecast for Covid-19 Products

Kamis, 28 Juli 2022 | 18:49 WIB
Pfizer Profit Surges, Reaffirms Sales Forecast for Covid-19 Products

ILUSTRASI. Pfizer Inc reported a 78% jump in profit and reaffirmed the combined 2022 sales forecast of US$ 54 billion for its Covid-19 vaccine and pill. REUTERS/Matthew Childs

Sumber: Reuters | Editor: Anastasia Lilin Yuliantina

KONTAN.CO.ID - Pfizer Inc on Thursday reported a 78% jump in profit and reaffirmed the combined 2022 sales forecast of US$ 54 billion for its Covid-19 vaccine and pill as demand for coronavirus products remains strong.

Shares rose 1% in premarket trading as overall net income rose to US$ 9,91 billion despite a stronger dollar.

Ini Artikel Spesial

Agar bisa lanjut membaca sampai tuntas artikel ini, pastikan Anda sudah berlangganan atau membeli artikel ini.

Sudah berlangganan? Masuk

Berlangganan

Berlangganan Hanya dengan 20rb/bulan Anda bisa mendapatkan berita serta analisis ekonomi, bisnis, dan investasi pilihan

Rp 20.000

Kontan Digital Premium Access

Business Insight, Epaper Harian + Tabloid, Arsip Epaper 30 Hari

Rp 120.000

Berlangganan dengan Google

Gratis uji coba 7 hari pertama. Anda dapat menggunakan akun Google sebagai metode pembayaran.

Terbaru
IHSG
7.288,81
0.29%
-21,28
LQ45
985,97
0.44%
-4,40
USD/IDR
15.853
0,35
EMAS
1.249.000
2,21%